adamantane has been researched along with arterolane in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 6 (75.00) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Alker, A; Charman, SA; Charman, WN; Chiu, FC; Dong, Y; Hunziker, D; Morizzi, J; Ruf, A; Scheurer, C; Vennerstrom, JL; Wang, X; Wittlin, S; Zhou, L | 1 |
Brughera, M; Colombo, P; Craft, JC; Longo, M; Moehrle, J; Vennerstrom, JL; Wittlin, S; Zanoncelli, S | 1 |
Anstey, NM; Chalfein, F; Haynes, RK; Kenangalem, E; Marfurt, J; Möhrle, JJ; Piera, KA; Prayoga, P; Price, RN; Sebayang, B; Wabiser, F; Wirjanata, G; Wittlin, S | 1 |
Charman, SA; Chiu, FC; Chollet, J; Dong, Y; Katneni, K; Mannila, J; Morizzi, J; Ryan, E; Santo Tomas, J; Scheurer, C; Snyder, C; Steuten, J; Vennerstrom, JL; Wang, X; Wittlin, S | 1 |
Iyengar, K; Roepe, PD; Siriwardana, A | 1 |
Baumgärtner, F; Blasco, B; Campo, B; Jourdan, J; Mäser, P; Scheurer, C; Wittlin, S | 1 |
Charman, SA; Creek, DJ; Giannangelo, C; Stingelin, L; Tilley, L; Yang, T | 1 |
Anderson, BM; Charman, SA; Creek, DJ; De Paoli, A; Edgington-Mitchell, LE; Giannangelo, C; Siddiqui, G | 1 |
8 other study(ies) available for adamantane and arterolane
Article | Year |
---|---|
Characterization of the two major CYP450 metabolites of ozonide (1,2,4-trioxolane) OZ277.
Topics: Adamantane; Antimalarials; Cytochrome P-450 Enzyme System; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Microsomes, Liver; Molecular Structure; Peroxides; Spiro Compounds | 2008 |
Comparative embryotoxicity of different antimalarial peroxides: in vitro study using the rat whole embryo culture model (WEC).
Topics: Adamantane; Animals; Antimalarials; Artemisinins; Branchial Region; Drug Evaluation, Preclinical; Embryo Culture Techniques; Embryo, Mammalian; Embryonic Development; Erythrocytes; Heterocyclic Compounds, 1-Ring; Inhibitory Concentration 50; No-Observed-Adverse-Effect Level; Peroxides; Plasmodium falciparum; Rats; Spiro Compounds; Structure-Activity Relationship; Teratogens; Yolk Sac | 2010 |
Comparative ex vivo activity of novel endoperoxides in multidrug-resistant plasmodium falciparum and P. vivax.
Topics: Adamantane; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Resistance, Multiple; Heterocyclic Compounds, 1-Ring; Microbial Sensitivity Tests; Peroxides; Plasmodium falciparum; Plasmodium vivax; Quinolines; Spiro Compounds | 2012 |
Comparative antimalarial activities and ADME profiles of ozonides (1,2,4-trioxolanes) OZ277, OZ439, and their 1,2-dioxolane, 1,2,4-trioxane, and 1,2,4,5-tetraoxane isosteres.
Topics: Absorption; Adamantane; Animals; Antimalarials; Dioxolanes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Male; Mice; Peroxides; Plasmodium berghei; Plasmodium falciparum; Spiro Compounds; Structure-Activity Relationship; Tetraoxanes | 2013 |
Endoperoxide Drug Cross-Resistance Patterns for Plasmodium falciparum Exhibiting an Artemisinin Delayed-Clearance Phenotype.
Topics: Adamantane; Antimalarials; Artemether; Artemisinins; Dose-Response Relationship, Drug; Drug Resistance; Heterocyclic Compounds, 1-Ring; Inactivation, Metabolic; Lethal Dose 50; Microbial Sensitivity Tests; Peroxides; Plasmodium falciparum; Spiro Compounds | 2016 |
In vitro activity of anti-malarial ozonides against an artemisinin-resistant isolate.
Topics: Adamantane; Antimalarials; Artemisinins; Drug Resistance; Heterocyclic Compounds, 1-Ring; Peroxides; Plasmodium falciparum; Spiro Compounds | 2017 |
Parasite-Mediated Degradation of Synthetic Ozonide Antimalarials Impacts
Topics: Adamantane; Antimalarials; Erythrocytes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Peroxides; Plasmodium falciparum; Spiro Compounds; Trophozoites | 2018 |
System-wide biochemical analysis reveals ozonide antimalarials initially act by disrupting Plasmodium falciparum haemoglobin digestion.
Topics: Adamantane; Antimalarials; Erythrocytes; Hemoglobins; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Peroxides; Plasmodium falciparum; Proteomics; Spiro Compounds | 2020 |